Rfaxis, Inc.
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03F (Amplifiers).
The verdict
According to USPTO PatentsView, Rfaxis ranks #33,072 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
- #33,072
- of 49,997 US assignees by volume
- 35th percentile
- by Innovation Score (30.5/100)
- 25.1
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R33072 · US Corporation #33,072 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #33,072/49,997
- PHOTO-FINISH Respire Medical…
- CPC-NARROW H03F · 5 areas
- INNOV-THIN 30.5/100
- CLAIMS-DENSE 25.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Respire Medical Holdings LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Rfaxis’s 30.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Rfaxis
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cirrus Data Solutions · near 31
Cirrus Data Solutions · near
31 score
- BIG Lift · near 31
BIG Lift · near
31 score
- Mesoblast · near 31
Mesoblast · near
31 score
- Nakanishi · near 31
Nakanishi · near
31 score
- Rfaxis · this assignee 31
Rfaxis · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Rfaxis's Innovation Score is 30.5/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Rfaxis?
Each dot is one of Rfaxis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rfaxis’s own 25.1 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Rfaxis's grants concentrate
Rfaxis, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 37.5% of grants classified under H03F (Amplifiers). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2016. By volume, Rfaxis sits between Respire Medical Holdings LLC and Rich Media Ventures, LLC.
Who files at Rfaxis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Respire Medical H…
Respire Medical Holdings LLC
8 patents
- Retinal Solutions
Retinal Solutions LLC
8 patents
- REV Robotics
REV Robotics LLC
8 patents
- RF Venue
RF Venue, Inc.
8 patents
- Rheinmetall AIR D…
Rheinmetall AIR Defence AG
8 patents
- Rhodia Chimie
Rhodia Chimie
8 patents
- Ribomic
Ribomic Inc.
8 patents
- Rich Media Ventur…
Rich Media Ventures, LLC
8 patents
- Rfaxis ◀
Rfaxis, Inc.
8 patents
What this shows Rfaxis holds 8 patents at rank #33,013, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rfaxis
By rank, the assignees closest to #33,013 in granted patent volume.
- Respire Medical Holdings LLC #33,009 · 8 patents
- Retinal Solutions LLC #33,010 · 8 patents
- REV Robotics LLC #33,011 · 8 patents
- RF Venue, Inc. #33,012 · 8 patents
- Rheinmetall AIR Defence AG #33,014 · 8 patents
- Rhodia Chimie #33,015 · 8 patents
- Ribomic Inc. #33,016 · 8 patents
- Rich Media Ventures, LLC #33,017 · 8 patents
Leaders in H03F (Amplifiers)
Other assignees with the most granted patents in Rfaxis's primary technology class.
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Rfaxis, neither rank-band nor same-CPC leaders (those blocks stay above). In H03F (Amplifiers), Rfaxis ranks #294 of 791 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (31 here).
Rfaxis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 35th percentile higher than 35% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 75.0% |
| 2016 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
Which technologies does Rfaxis, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Rfaxis, Inc.'s patent record in context - here's where to go next.
- Rfaxis, Inc.'s lead technology class is H03F (Amplifiers), 37.5% of its portfolio - see every assignee active in that class. Explore H03F
- Ranked #33,072 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Rfaxis, Inc. against Respire Medical Holdings LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.